Braidwell LP decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 75,300 shares of the medical equipment provider's stock after selling 16,000 shares during the period. Braidwell LP's holdings in Intuitive Surgical were worth $39,304,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. 83.64% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on ISRG. Truist Financial reduced their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Evercore ISI dropped their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Finally, BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.
Get Our Latest Research Report on ISRG
Intuitive Surgical Trading Down 0.3 %
Shares of NASDAQ ISRG traded down $1.61 during midday trading on Friday, hitting $536.55. 925,598 shares of the company's stock were exchanged, compared to its average volume of 1,631,682. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The business's fifty day moving average price is $500.93 and its two-hundred day moving average price is $534.86. The company has a market cap of $192.31 billion, a price-to-earnings ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the business earned $1.50 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.